What is a stock summary page? Click here for an overview.
Business Description
AnGes Inc
ISIN : JP3127700007
Description
AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.27 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -28.48 | |||||
| Beneish M-Score | -23.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 84.4 | |||||
| 3-Year EBITDA Growth Rate | 35.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.3 | |||||
| 3-Year FCF Growth Rate | 28.5 | |||||
| 3-Year Book Growth Rate | -69 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.6 | |||||
| 14-Day RSI | 5.28 | |||||
| 6-1 Month Momentum % | -33.53 | |||||
| 12-1 Month Momentum % | -22.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | |||||
| Quick Ratio | 0.91 | |||||
| Cash Ratio | 0.74 | |||||
| Days Inventory | 1388.79 | |||||
| Days Sales Outstanding | 53.57 | |||||
| Days Payable | 343.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.2 | |||||
| Shareholder Yield % | -14.35 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.49 | |||||
| Operating Margin % | -1415.31 | |||||
| Net Margin % | -4370.31 | |||||
| FCF Margin % | -1029.27 | |||||
| ROE % | -139.25 | |||||
| ROA % | -122.95 | |||||
| ROIC % | -47.06 | |||||
| 3-Year ROIIC % | -23.2 | |||||
| ROC (Joel Greenblatt) % | -2185.92 | |||||
| ROCE % | -52.13 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 23.19 | |||||
| PB Ratio | 8.76 | |||||
| Price-to-Tangible-Book | 9.01 | |||||
| EV-to-EBIT | -1.62 | |||||
| EV-to-EBITDA | -1.86 | |||||
| EV-to-Revenue | 27.14 | |||||
| EV-to-FCF | -2.61 | |||||
| Price-to-GF-Value | 0.1 | |||||
| Price-to-Median-PS-Value | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 18.01 | |||||
| Earnings Yield (Greenblatt) % | -61.73 | |||||
| FCF Yield % | -35.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AMGXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AnGes Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.226 | ||
| EPS (TTM) ($) | -0.785 | ||
| Beta | 0.16 | ||
| 3-Year Sharpe Ratio | -1.03 | ||
| 3-Year Sortino Ratio | -1.26 | ||
| Volatility % | 76.06 | ||
| 14-Day RSI | 5.28 | ||
| 14-Day ATR ($) | 0.000016 | ||
| 20-Day SMA ($) | 0.3602 | ||
| 12-1 Month Momentum % | -22.22 | ||
| 52-Week Range ($) | 0.3353 - 0.5419 | ||
| Shares Outstanding (Mil) | 286.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AnGes Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AnGes Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AnGes Inc Frequently Asked Questions
What is AnGes Inc(AMGXF)'s stock price today?
The current price of AMGXF is $0.36. The 52 week high of AMGXF is $0.54 and 52 week low is $0.34.
When is next earnings date of AnGes Inc(AMGXF)?
The next earnings date of AnGes Inc(AMGXF) is .
Does AnGes Inc(AMGXF) pay dividends? If so, how much?
AnGes Inc(AMGXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers